Submit your email to push it up the queue
Elanco Tiergesundheit AG, a prominent player in the animal health industry, is headquartered in Switzerland (CH) and operates extensively across Europe and beyond. Founded in 1954, Elanco has established itself as a leader in providing innovative solutions for livestock and companion animals, focusing on improving animal health and welfare. The company offers a diverse range of products and services, including vaccines, pharmaceuticals, and nutritional supplements, all designed to enhance animal productivity and well-being. Elanco's commitment to research and development sets it apart, ensuring that its offerings are both effective and sustainable. With a strong market position, Elanco Tiergesundheit AG has achieved notable milestones, including significant advancements in animal health technologies. The company continues to be recognised for its contributions to the industry, making it a trusted partner for veterinarians and farmers alike.
How does Elanco Tiergesundheit AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Elanco Tiergesundheit AG's score of 60 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Elanco Tiergesundheit AG, headquartered in Switzerland (CH), currently does not report specific carbon emissions data, as indicated by the absence of figures in the latest emissions data. The company is a current subsidiary of Elanco Animal Health Incorporated, which may influence its climate commitments and reporting practices. While no specific reduction targets or achievements are available for Elanco Tiergesundheit AG, it is important to note that its parent company, Elanco Animal Health Incorporated, is involved in various climate initiatives. These include commitments to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP). However, specific targets or performance metrics from these initiatives have not been disclosed for Elanco Tiergesundheit AG. As a subsidiary, Elanco Tiergesundheit AG may align its climate strategies with those of Elanco Animal Health Incorporated, focusing on sustainability and reducing environmental impact. The lack of detailed emissions data and reduction targets highlights the need for further transparency in their climate commitments.
Access structured emissions data, company-specific emission factors, and source documents
2015 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|
Scope 1 | 274,550,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 2 | 418,271,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 3 | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Elanco Tiergesundheit AG is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.